- $23.50bn
- $29.41bn
- $12.32bn
- 31
- 46
- 97
- 59
2019 June 28th | 2020 July 3rd | 2021 July 2nd | 2022 July 1st | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16,569 | 16,736 | 16,922 | 18,793 | 12,318 |
Cost of Revenue | |||||
Gross Profit | 3,897 | 3,849 | 4,573 | 6,322 | 1,887 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 16,482 | 16,401 | 15,702 | 16,402 | 13,603 |
Operating Profit | 87 | 335 | 1,220 | 2,391 | -1,285 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -287 | -46 | 927 | 2,123 | -1,560 |
Provision for Income Taxes | |||||
Net Income After Taxes | -635 | -250 | 821 | 1,500 | -1,706 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -754 | -250 | 821 | 1,500 | -1,706 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -754 | -250 | 821 | 1,500 | -1,730 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.48 | -0.621 | 2.67 | 5.84 | -5.05 |
Dividends per Share |